ArticleCancer management and research2023

Osimertinib for an Advanced NSCLC Patient with Two Common EGFR Mutations and a Concomitant MET Exon 14 Skipping Mutation: A Case Report.

Zhicong Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.